Related Experiment Video
Updated: Jan 18, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Views of Menopause and Hormone Therapy Associations with Hormone Therapy Use in US Women Aged 50-79
Sushmita Chopra1, Dokyung Yoon1, Teal Eich1
1The Davis School of Gerontology, University of Southern California, Los Angeles, California, USA.
Objective:
To explore symptoms, knowledge levels, perceptions, and use related to menopause and hormone therapy (HT) and to examine the factors associated with HT use and HT perceptions in perimenopausal and postmenopausal women.
Materials And Methods:
We used a sample of 98 perimenopausal and postmenopausal women who aged 50-79 and participated in the Sex, ApoE-4, γ-aminobutyric acid, and Episodic memory (SAGE) study (M age = 64.24, standard deviation = 7.49). We applied a series of bivariate Firth logistic regressions to examine the associations of each variable of interest with hormone therapy (HT) use and perceptions.
Results:
Overall, 89.90% reported positive perceptions of menopause, and 85.71% had positive perceptions of HT. One-third (32.65%) of the sample had used HT. Hot flashes (72.4%) were the most reported menopausal symptom. Logistic regression analyses showed that age, race/ethnicity, current drinking status, menopausal knowledge levels, and vasomotor and genitourinary symptoms were significantly associated with HT use, while race/ethnicity, current drinking status, menopausal knowledge levels, and genitourinary symptoms were also linked to positive HT perceptions. Hispanic participants reported lower menopausal knowledge, less positive HT perceptions, and lower HT use.
Conclusions:
The majority of women in the SAGE cohort reported positive perceptions of both menopause and HT. Race/ethnicity, along with current drinking status, menopausal knowledge levels, and genitourinary symptoms, were consistently associated with both HT use and HT perceptions. Ethnic differences in menopausal knowledge levels, HT perceptions, and HT use are also discussed.
More Related Videos
05:32Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model
Published on: August 11, 2023
14:26A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
Published on: April 7, 2014
Related Concept Videos
Menopause
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Hormonal Regulation
Hormonal Regulation
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...